COVID-19 response in northwest Syria: innovation and community engagement in a complex conflictEditor's Choice Published on 2020-08-212022-10-30 Journal: Journal of public health (Oxford, England) [Category] COVID-19, MERS, [키워드] affected approach Community complex COVID-19 develop effort health information Health messaging health system Idleb Infectious disease lesson Local mechanism network outbreak pandemic polio population-based and preventative services Prevent resource resources response risk scaled up Seasonal influenza social distancing social media Surveillance Syria Transmission Volunteer war WhatsApp white [DOI] 10.1093/pubmed/fdaa068 PMC 바로가기 [Article Type] Editor's Choice
Knowledge, Attitude, and Practice of the Lebanese Community Toward COVID-19Medicine Published on 2020-08-182022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] adopted age analysis of variance Attitude calculated claimed conducted coughing country COVID-19 COVID-19 symptoms cross-sectional Descriptive statistics evaluate extreme Face mask group involved knowledge Lebanese mandatory measure MOST outbreak pandemic participant positive result Practice Prevent PROTECT question questionnaire reflected SARS-CoV-2 sick Sociodemographic SPSS survey tissue Volunteer was performed [DOI] 10.3389/fmed.2020.00542 PMC 바로가기 [Article Type] Medicine
Collaboration during a crisis – the Lighthouse Lab volunteersPersonal View Published on 2020-07-282022-10-30 Journal: Microbiology [Category] COVID-19, SARS, [키워드] collaboration coronavirus disease COVID-19 Lighthouse Lab National pandemic researchers Support Swab Teamwork Volunteer volunteers [DOI] 10.1099/mic.0.000960 PMC 바로가기 [Article Type] Personal View
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issuesPerspectives Published on 2020-07-222022-10-28 Journal: The Pan African Medical Journal [Category] COVID-19, MERS, SARS, [키워드] candidate vaccine clinical trial COVID-19 COVID-19 vaccine COVID-19 virus drugs Ethics global effort management media molecular target MONITOR pandemic platform Research resource risk the vaccine timelines Trial Vaccine Vaccine development Volunteer [DOI] 10.11604/pamj.2020.36.206.23977 PMC 바로가기 [Article Type] Perspectives
Exploring the acceptability of controlled human infection with SARSCoV2—a public consultationCorrespondence Published on 2020-07-072022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] accelerate benefit complex conducted Controlled human infection model COVID-19 death dissemination domain effective Efficacy enrolment Final human infection individual individuals Infection information positive Public consultation question raise Rapid required risk SARSCoV2 significant level social isolation supportive care Treatment Vaccine Vaccines virus Volunteer [DOI] 10.1186/s12916-020-01670-2 PMC 바로가기 [Article Type] Correspondence
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-292022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 Absorption administration All participant anticipated Area assigned AUC C max center changes in clinical Concentration control group Corona Course COVID-19 CYP2D6 CYP3A4 dissemination dose drug drug-drug interaction element enrolment enzyme activity Enzymes EudraCT Germany HCQ Hydroxychloroquine Impact inhibitor investigator Microdosing Midazolam mononuclear cell not blinded number objective Open-label outcome P450 Pantoprazole parallel group participant Patient PBMC PBMCs performed Peripheral blood Phase I plasma PPI probe protocol randomisation list randomised randomised controlled trial Randomized receive recruitment Registered registry reported Sample size secondary single dose Standard status Study protocol target cell treated treatment group Trial trial protocol Two-arm university Volunteer website Whole blood Yohimbine [DOI] 10.1186/s13063-020-04476-y PMC 바로가기 [Article Type] Letter
Calling for an exponential escalation scheme in vaccine development for COVID-19Point of View Published on 2020-06-162022-10-31 Journal: European Journal of Clinical Pharmacology [Category] COVID-19, MERS, SARS, [키워드] accelerated adaptive adaptive design antibody COVID-19 COVID-19 vaccine described Efficacy Escalation exponential growth feasible increased risk meet pandemic responses Result seamless Seamless trial design Side effect starting Surveillance Trial vaccination Vaccine development Vaccines Volunteer [DOI] 10.1007/s00228-020-02933-w PMC 바로가기 [Article Type] Point of View
Covid-19 Outbreak In Italy: Are We Ready for the Psychosocial and the Economic Crisis? Baseline Findings From the PsyCovid StudyPsychiatry Published on 2020-06-102022-10-31 Journal: Frontiers in Psychiatry [Category] COVID-19, [키워드] affected age Consensus Consequences Contagion coping abilities Coping strategy COVID-19 outbreak distress economic crisis Effect empathy evaluated Factors finding frailty Health healthcare Healthcare system healthcare worker Intervention Italian Italian population Italy loneliness modulated outbreak outcome outcomes pandemic perceived impact on health Psychological Psychosocial psychosocial frailty Region regions reported Resilience Responder severity significantly social isolation Support tested variable Volunteer whole sample [DOI] 10.3389/fpsyt.2020.00556 PMC 바로가기 [Article Type] Psychiatry
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-06-082022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] activity adverse event allergic reaction anti-SARS-CoV-2 anti-SARS-CoV-2 antibody Anti-SARS-CoV-2 plasma Anti-viral blinded Blood blood product center Chest radiography Clinical improvement Clinical outcome clinical status clinical trial clinician collected Columbia University control arm convalescent plasma coronavirus COVID-19 COVID-19 symptom criteria cumulative Date defined Dilution discharge dissemination Donor ECMO Efficacy Efficacy and safety element evaluate Evaluating Evidence extracorporeal membrane oxygenation hazard hazard ratio HBV HCV HIV hospital Hospitalized hospitalized patient IgA deficiency immune incidence include Infection Influenza Invasive mechanical ventilation mechanical ventilation multi-organ failure nasopharyngeal Nasopharyngeal swab New York Non-invasive number objective occur oropharyngeal swab outcome oxygen saturation participant Participants patients hospitalized PCR test PCR-negative per-protocol analysis peripheral capillary plasma platform post-hoc analysis Pregnancy primary endpoint protocol randomization Randomized Randomized controlled trial randomized, controlled trial randomly permuted block receive Registered Remdesivir requiring high-flow oxygen requiring supplemental oxygen Research Respiratory failure retrospective Ritonavir safety endpoint Sample size SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection screened Serious Adverse Event seven-point ordinal scale severe COVID-19 severe SARS-CoV-2 severely ill adult single-center spike trimer SpO2 status study participant study period Study protocol supplemental oxygen tested therapy transfused Treatment treatment for COVID-19 Trial undergo USA Version Volunteer Wald test website with COVID-19 World Health Organization ZIKV [DOI] 10.1186/s13063-020-04422-y PMC 바로가기 [Article Type] Letter
Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative PhenotypesSARS-CoV-2 감염 및 인간의 정량적 표현형에 관여하는 ACE2 및 TMPRSS2 유전자의 유전적 변이체 간의 연관성 부족Genetics Published on 2020-06-082022-08-13 Journal: Frontiers in Genetics [Category] 유전자 메커니즘, [키워드] ACE2 ACE2 gene acute respiratory distress acute respiratory distress syndrome angiotensin angiotensin converting enzyme Angiotensin II Anti-inflammatory ARBs ARBs (angiotensin II receptor blockers) association associations Biomarkers blocker carried cause causes Cell chronic inflammation Cohort combination therapies combination therapy coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient cytokine Cytokines death disease enzyme examined example expression female females flu-like symptoms General population genetic data Genetic predisposition Genetic variant Genetic variation genetics Human human genes hypertension include Infection Invasion male medication medications Mild modulate multifactorial no symptoms NSAIDs (non-steroidal anti-inflammatory drugs) nucleotide outcome phenotype PheWAS Pneumonia priming Quantitative reached receptor Receptor Blockers respiratory distress Respiratory distress syndrome responsible S protein sample sizes SARS-CoV-2 SARS-CoV-2 virus Serine serine protease serine protease TMPRSS2 severe cases severe COVID-19 severity of symptoms significantly Single nucleotide polymorphism single nucleotide polymorphisms SNP SNPs syndrome threshold thrombocyte Thrombocytes thrombocytopenia TMPRSS2 Usage Variability variant Variation virus clearance Volunteer while [DOI] 10.3389/fgene.2020.00613 PMC 바로가기 [Article Type] Genetics